Palatin to investigate MC4R agonist as a potentially effective and safe treatment for obesity
Palatin Technologies, a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of...
Palatin to investigate MC4R agonist as a potentially effective and safe treatment for obesity
Examining how endogenous cannabinoids regulate body weight
Visualising structure of MC4R protein could aid obesity treatments